相关实验视频
Updated: Sep 13, 2025
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
在急性缺血性轻度中风中的静脉血栓溶解:丹麦全国范围的队列研究
Daniel Harsfort1, Jakob Nebeling Hedegaard2, Søren Paaske Johnsen2
1Department of Neurology, Aalborg University Hospital, Denmark.
概括
内静脉血栓溶解改善了轻度中风患者的治疗结果,改善了恢复工作并降低了死亡率. 然而,在非常轻微的中风病例中,益处较小,只有365天的死亡率有所改善.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 公共卫生 公共卫生
背景情况:
- 内静脉血栓溶解推给轻微的中风患者残疾症状,但缺乏标准化的定义,导致主观的治疗决定.
- 这项研究解决了使用现实世界注册数据对小型中风中血栓溶解有效性的客观数据的需求.
研究的目的:
- 评估静脉输血栓溶解对轻度中风患者结果的影响.
- 根据中风的严重程度 (轻度与非常轻度) 来区分血栓溶解的影响.
主要方法:
- 一项全国性的丹麦队列研究分析了2011-2021年间31007名轻度中风患者 (斯堪的纳维亚中风量 ≥45) 的数据.
- 患者被分为轻度 (SSS 45-49) 和非常轻度 (SSS 50-58) 的中风组.
- 包括返回工作,家庭护理使用,并发症,复发性中风和死亡率在内的结果在治疗和未治疗组之间进行了比较,并使用治疗权重的逆概率对混因子进行了调整.
主要成果:
- 在轻度中风患者中,血栓溶解与更高的恢复工作率 (aHR 1.33) 和降低肺炎风险 (aRR 0.40) 相关.
- 在轻度中风患者中,血栓溶解显著降低了30,90和365天的死亡率 (aRR为0.58,0.50,0.50).
- 在非常轻度的中风患者中,除了减少365天死亡率 (aRR0.78) 外,血栓溶解没有显著的益处.
结论:
- 内静脉血栓溶解在轻度中风患者中比在非常轻度中风患者中具有更大的益处.
- 这些发现表明,根据症状严重程度,在轻微中风中需要采取更有针对性的血栓溶解方法.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
37
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
37
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44